Search results

Source:

Medicines Management Collection (Remove filter)

Published by Research In Social & Administrative Pharmacy : Rsap, 12 July 2018

INTRODUCTION: While many attempts have been made to reduce prescribing errors (PEs), they persist. PE is not in itself a behaviour, but a consequence...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group (AWMSG), 13 November 2019

This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.*

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group (AWMSG), 01 December 2018

Four medicines/medicine groups have been identified for the purposes of this document: omega-3 fatty acid compounds, oxycodone and naloxone combination product, paracetamol and tramadol combination...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

Medicines Management Collection (Remove filter)

Published by Journal Of The American Pharmacists Association : Japha, 03 September 2018

OBJECTIVES: To evaluate community pharmacists' reimbursed prescribing interventions (called pharmaceutical opinions/POs in Canada) by determining the...

Read Summary

Type:

Audit and Inspection Reports (Remove filter)

Source:

All Wales Medicines Strategy Group - AWMSG (Remove filter)

Published by All Wales Medicines Strategy Group (AWMSG), 01 June 2015

The aims of the audit are to promote antibiotic prescribing in accordance with existing guidelines and to support clinicians in promoting quality improvement by reviewing antimicrobial prescribing...

Read Summary

Type:

Audit and Inspection Reports (Remove filter)